health

Danish firm behind weight-loss drug Wegovy raises profit forecast to £15.3bn

By
1 Mins read
48
0
Share
Reading Time: < 1 minute

Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its 2024 profit forecast to up to £15.3bn, with supply shortages starting to ease. Read More

48
0
Share
Related posts
health

Ex-Taliban fighters helping charities locate landmines they planted in Afghanistan

By
1 Mins read
Reading Time: < 1 minute Former Taliban fighters are tracking down their own bombs and helping to remove them from Afghanistan’s roadsides.  Read More
health

Millions of sick people still going to work due to money worries - as 14% get office bugs

By
1 Mins read
Reading Time: < 1 minute Millions of sick people are not taking time off work or are returning to work while still unwell due to money worries,…
health

Streeting admits patients are no longer confident the NHS will be there when it's needed

By
1 Mins read
Reading Time: < 1 minute Health Secretary Wes Streeting admits millions of fed-up patients are no longer confident the NHS will be there when they need it. …
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.